Dr. Gabriela Chiosis’ research focuses on understanding how stressors—internal and external factors disrupting biological systems—impact human diseases. Recognizing the complexity of diseases that involve multifaceted origins and cellular responses, her work shifts away from traditional protein-centered approaches. Instead, it manipulates epichaperomes to target protein-protein interaction (PPI) networks that dictate cellular responses to stressors, affecting entire biological systems. By mapping these networks and their dysfunctions, her research aims to develop precise, effective treatments for complex diseases like cancer and neurodegenerative disorders, thereby advancing the field of network precision medicine.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Gabriela Chiosis discloses the following relationships and financial interests:
-
Samus Therapeutics LLC
Equity; Intellectual Property Rights
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures